#EXP00316

General

Accession	EXP00316
Activity	Formation (3-24h)
Date	2014-12-01
Administration	In solution
Model	in vitro

Organism	Staphylococcus aureus Smith diffuse SD)
Status	Validated
Notes	No notes

Peptide

BMAP-28

GGLRSLGRKILRAWKKYGPIIVPIIRI

Experimental activity

Method	Concentration	Notes
Crystal violet assay	325.422 uM	No notes

References

Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection

Oscar Cirioni, Andrea Giacometti, Roberto Ghiselli, Cristina Bergnach, Fiorenza Orlando, Federico Mocchegiani, Carmela Silvestri, Alberto Licci, Barbara Skerlavaj, Margherita Zanetti, Vittorio Saba, Giorgio Scalise

2006. Peptides 9:2104-2110